Systemic and lung-resident memory elicited by OC43 coronavirus infection in mice

N Nathan L Sanders (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) D Devin Kenney (Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine) N Neelou S Etesami (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) A Anukul T Shenoy (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) K Konstantinos Kontodimas (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) J Julian Amirault (Boston University Chobanian and Avedisian School of Medicine) C Chioma Okolo (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) V Viviana A Dominguez (Department of Medicine, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,) M Marc Semaan (Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine) E Ekaterina Murzin (Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,) J James A Lederer (Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,) F Florian Douam (National Emerging Infectious Diseases Laboratories, Boston University) M Mohsan Saeed (Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine) J Joseph P Mizgerd (Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,)

Abstract

Abstract Endemic coronaviruses circulate seasonally and, while typically mild, can produce robust inflammation and severe pneumonia. Immunological memory to coronaviruses can be cross-reactive for multiple coronaviruses including OC43 and SARS-CoV-2. In this study, we used mouse models to investigate immune responses elicited by pulmonary infection with OC43. OC43 caused a mild, self-limiting infection. Early after infection, there was acute influx of myeloid cells and lymphocytes to the lung as well as a type I interferon–dependent production of IFN-γ. However, blocking interferons did not enhance viral infection. After recovery, lungs contained resident memory lymphocytes, and both the blood and lungs contained antibodies against OC43. When infection was supplemented with proinflammatory stimuli to model more severe disease, OC43-elicited immune changes were bolstered, including increased virus-specific plasma IgG and lung IgA, enhanced lung B-cell class-switching, and increased antigen-specific Th1 and Th17 cytokine production from lung CD4+ T cells. The antibodies and CD4+ T cells in mice recovered from OC43 infection, even with immunostimulatory agents, reacted only with OC43 proteins and peptides and not with those from other coronaviruses. Therefore, OC43 infection in wild-type mice does not induce the heterotypic immunity observed in humans. In conclusion, OC43 induces a self-limiting lung infection in mice accompanied by homotypic lung-resident and systemic memory, amplified by proinflammatory stimuli during infection.

Article Details

Volume / Issue Vol. 215, Issue 7
Published July 10, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (14)

N

Nathan L Sanders

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

D

Devin Kenney

Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine

N

Neelou S Etesami

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

A

Anukul T Shenoy

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

K

Konstantinos Kontodimas

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

J

Julian Amirault

Boston University Chobanian and Avedisian School of Medicine

C

Chioma Okolo

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

V

Viviana A Dominguez

Department of Medicine, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,

M

Marc Semaan

Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine

E

Ekaterina Murzin

Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,

J

James A Lederer

Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,

F

Florian Douam

National Emerging Infectious Diseases Laboratories, Boston University

M

Mohsan Saeed

Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine

J

Joseph P Mizgerd

Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,